Impact of ABC pathway adherence in high-risk patients with atrial fibrillation: an analysis from the ESC-EHRA EORP-AF long-term general registry

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Wern Yew Ding

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail

Risk of stroke and transient ischemic attack after elective cardioversion of atrial fibrillation: A nationwide study in Finland

Mrs S. Itainen-Stromberg (Helsinki, FI)

Abstract Slides

Presentation thumbnail

Clinical risk prediction for left atrial appendage thrombus among patients with atrial fibrillation

Professor P. Kistler (Melbourne, AU)

Abstract Slides

Presentation thumbnail

Left atrial appendage occlusion versus standard of care in patients with atrial fibrillation and a prior thrombo-embolic event despite oral anticoagulant therapy: a propensity score matched comparison

Professor L. Boersma (Nieuwegein, NL)

Abstract Slides

Presentation thumbnail

Decreased device related thrombus and enhanced neo-endocardial tissue maturation with a new generation left atrial appendage closure (LAAC) device. An anticoagulation and antiplatelet free canin study

Professor W. Saliba (Cleveland, US)

Abstract Slides

Access the full session

Session thumbnail

Stroke prevention by anticoagulation and appendage occlusion in atrial fibrillation

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Presentation

Interactive discussion and Q&A

Congress Session

Treatment strategies for atrial fibrillation in heart failure

Congress Session

EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources